Stockscreener 앱 받기
22.64
5.67%
-1.36
전일 마감가:
$24.00
열려 있는:
$24.21
하루 거래량:
1.22M
Relative Volume:
1.49
시가총액:
$1.65B
수익:
$193.35M
순이익/손실:
$-177.58M
주가수익비율:
-9.2408
EPS:
-2.45
순현금흐름:
$-172.43M
1주 성능:
-8.89%
1개월 성능:
+6.14%
6개월 성능:
+12.69%
1년 성능:
-24.61%
1일 변동 폭
$22.05
$24.50
1주일 범위
$22.05
$28.47
52주 변동 폭
$16.67
$33.63
슈뢰딩거 Stock (SDGR) Company Profile
명칭
Schrodinger Inc
전화
503-299-1150
주소
1540 BROADWAY, NEW YORK, NY
SDGR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SDGR
Schrodinger Inc
|
22.64 | 1.65B | 193.35M | -177.58M | -172.43M | -2.45 |
|
VEEV
Veeva Systems Inc
|
225.79 | 36.66B | 2.66B | 665.91M | 1.08B | 4.05 |
|
DOCS
Doximity Inc
|
72.37 | 13.58B | 516.85M | 174.11M | 217.38M | 0.87 |
|
SOLV
Solventum Corp
|
73.02 | 12.61B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
TEM
Tempus Ai Inc
|
68.09 | 10.72B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
108.60 | 9.41B | 1.15B | 96.70M | -161.99M | 1.09 |
슈뢰딩거 Stock (SDGR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-02 | 개시 | Leerink Partners | Outperform |
| 2023-12-05 | 개시 | KeyBanc Capital Markets | Overweight |
| 2023-05-05 | 재개 | Piper Sandler | Overweight |
| 2022-12-19 | 개시 | Goldman | Neutral |
| 2022-03-01 | 개시 | Citigroup | Buy |
| 2021-11-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-19 | 개시 | Piper Sandler | Overweight |
| 2021-11-11 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-10-13 | 개시 | Berenberg | Buy |
| 2021-09-01 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-25 | 개시 | Craig Hallum | Buy |
| 2020-11-23 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-10-12 | 업그레이드 | Jefferies | Hold → Buy |
| 2020-03-02 | 개시 | BMO Capital Markets | Outperform |
| 2020-03-02 | 개시 | Jefferies | Hold |
| 2020-03-02 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
슈뢰딩거 주식(SDGR)의 최신 뉴스
Schrödinger, Inc. (NASDAQ:SDGR) Shares Sold by Baillie Gifford & Co. - MarketBeat
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Schrödinger (NASDAQ:SDGR) Shares Gap UpStill a Buy? - MarketBeat
(SDGR) Trading Advice - Stock Traders Daily
Schrödinger (SDGR) Projected to Post Earnings on Wednesday - MarketBeat
Why Xpeng (XPEV) and Schrodinger (SDGR) Are Advancing Today - Yahoo Finance
Schrödinger, Inc. (NASDAQ:SDGR) Shares Sold by Stanley Laman Group Ltd. - MarketBeat
Schrödinger, Inc. (NASDAQ:SDGR) Shares Sold by Yousif Capital Management LLC - Defense World
Hunterbrook Capital long ‘key AI winner’ Schrodinger - MSN
Schrödinger: An Interesting Investment With Immense Potential - Seeking Alpha
Schrödinger (SDGR): Revolutionizing Biopharma with Quantum Mechanics and AI - MSN
Schrodinger Stock Scores IBD Rating Upgrade - MSN
Schrodinger EVP Yvonne Tran sells $20,228 in stock - MSN
Sumitomo Mitsui Trust Group Inc. Acquires 1,319,464 Shares of Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat
Schrodinger EVP Kenneth Lorton sells $24,063 in common stock - MSN
Stephens Investment Management Group LLC Has $31.01 Million Stock Position in Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat
Schrodinger SVP Jenny Herman sells shares for $20,985 By Investing.com - Investing.com Australia
Schrödinger to Announce Fourth Quarter and Full-Year 2024 Financial Results on February 26 - BioSpace
Schrodinger EVP Yvonne Tran sells $20,228 in stock By Investing.com - Investing.com Nigeria
Schrodinger SVP Jenny Herman sells shares for $20,985 - Investing.com
Schrodinger Executives Sell Shares to Cover Tax Liabilities - TradingView
Schrödinger, Inc. (NASDAQ:SDGR) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Schrodinger Inc (SDGR) Shares Up 4.21% on Feb 5 - GuruFocus.com
Schrödinger, Inc. (NASDAQ:SDGR) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Schrodinger stock soars; Hunterbrook positive as AI integration promises drug discovery advances - MSN
Top 5 AI & Digital Biotech Companies (February 2025) - Securities.io
Strong week for Schrödinger (NASDAQ:SDGR) shareholders doesn't alleviate pain of five-year loss - Yahoo Finance
First Week of February 21st Options Trading For Schrodinger (SDGR) - Nasdaq
Schrodinger Inc to Host Earnings Call - ACCESS Newswire
Schrodinger (SDGR) Stock Surges Amid Positive Analyst Ratings - GuruFocus.com
10 AI News And Ratings on Wall Street’s Radar - Insider Monkey
Schrödinger Adopts the Sapio Platform to Enhance In Silico Drug Discovery - Contract Pharma
(SDGR) Investment Analysis - Stock Traders Daily
AI Pharma: 2 Paths to AI-Powered Drug Investment - MarketBeat
Schrödinger (NASDAQ:SDGR) Stock Price Expected to Rise, KeyCorp Analyst Says - Defense World
KeyCorp Raises Schrödinger (NASDAQ:SDGR) Price Target to $27.00 - MarketBeat
슈뢰딩거 (SDGR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
슈뢰딩거 주식 (SDGR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Tran Yvonne | EVP, CLO & CPO |
Feb 18 '25 |
Sale |
28.00 |
3,902 |
109,256 |
11,135 |
9.30%
2.95%
자본화:
|
볼륨(24시간):